[Federal Register: June 1, 2006 (Volume 71, Number 105)]
[Notices]               
[Page 31192]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01jn06-69]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Surveillance and Epidemiologic Research of 
Duchenne and Becker Muscular Dystrophy and Other Single Gene Disorders, 
Request for Applications (RFA) Number DD06-002

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Surveillance and Epidemiologic 
Research of Duchenne and Becker Muscular Dystrophy and Other Single 
Gene Disorders, Request for Applications (RFA) Number DD06-002.
    Time and Date: 12 p.m.-5 p.m., June 27, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: To conduct expert review of scientific 
merit of research applications: Surveillance and Epidemiologic 
Research of Duchenne and Becker Muscular Dystrophy and Other Single 
Gene Disorders, RFA Number DD06-002.

FOR FURTHER INFORMATION CONTACT: Juliana Cyril, PhD., Scientific Review 
Administrator, Centers for Disease Control, 1600 Clifton Road, NE., 
Mail Stop D-72, Atlanta, GA 30333, Telephone 404.639.4639.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: May 24, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E6-8443 Filed 5-31-06; 8:45 am]

BILLING CODE 4163-18-P